Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 06-2010 | 12-2009 | 06-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,740 | 0 | -2,190 | 0 | -53,230 |
| Depreciation Amortization | 5,100 | 0 | 5,480 | 0 | 10,010 |
| Other Working Capital | 14,680 | 0 | -9,080 | 0 | -17,800 |
| Other Operating Activity | 11,450 | 0 | 32,090 | 0 | 69,360 |
| Operating Cash Flow | $40,970 | $0 | $26,300 | $0 | $8,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,490 | 0 | -7,510 | 0 | -7,790 |
| Other Investing Activity | 310 | 0 | -160 | 0 | 1,490 |
| Investing Cash Flow | $-6,180 | $0 | $-7,670 | $0 | $-6,300 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -34,010 | 0 | -30,690 | 0 | -3,890 |
| Financing Cash Flow | $-34,010 | $0 | $-30,690 | $0 | $-3,890 |
| Exchange Rate Effect | 2,930 | 0 | -1,250 | 0 | 8,900 |
| Beginning Cash Position | 41,750 | 0 | 55,580 | 0 | 58,800 |
| End Cash Position | 44,680 | 0 | 42,270 | 0 | 65,850 |
| Net Cash Flow | $2,930 | $0 | $-13,310 | $0 | $7,040 |
| Free Cash Flow | |||||
| Operating Cash Flow | 40,970 | 0 | 26,300 | 0 | 8,340 |
| Free Cash Flow | 40,970 | 0 | 26,300 | 0 | 8,340 |